A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma (Q40778810)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma |
scientific article |
Statements
1 reference
A phase II randomized study of lenalidomide or lenalidomide and rituximab as maintenance therapy following standard chemotherapy for patients with high/high-intermediate risk diffuse large B-cell lymphoma (English)
1 reference
N M Reddy
1 reference
J P Greer
1 reference
D S Morgan
1 reference
H Chen
1 reference
S I Park
1 reference
K L Richards
1 reference
22 September 2016
1 reference
1 reference
31
1 reference
1
1 reference
241-244
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference